![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Valeant CEO Takes Medical Leave
Valeant CEO Takes Medical Leave
Valeant Pharmaceuticals International CEO J. Michael Pearson has taken a medical leave of absence, leaving a team of executives to run the Canadian drugmaker on an interim basis.
Pearson, 56, has been hospitalized with severe pneumonia, according to the company, whose board has formed a new committee to oversee and support the interim executive team. That team immediately faces a series of controversies — including congressional questions about its product pricing and an insider trading lawsuit.
Upcoming Events
-
21Oct